RUSSO, Simonetta
 Distribuzione geografica
Continente #
NA - Nord America 1.584
AS - Asia 1.423
EU - Europa 1.261
SA - Sud America 223
AF - Africa 86
Totale 4.577
Nazione #
US - Stati Uniti d'America 1.541
SG - Singapore 468
CN - Cina 418
FI - Finlandia 273
VN - Vietnam 253
IT - Italia 224
DE - Germania 213
IE - Irlanda 188
BR - Brasile 180
SE - Svezia 158
HK - Hong Kong 79
TR - Turchia 64
FR - Francia 63
ZA - Sudafrica 52
GB - Regno Unito 33
NL - Olanda 30
IN - India 23
CI - Costa d'Avorio 21
AR - Argentina 18
BD - Bangladesh 18
CA - Canada 17
MX - Messico 17
UA - Ucraina 15
BE - Belgio 14
JP - Giappone 14
ID - Indonesia 13
IQ - Iraq 11
RU - Federazione Russa 11
CZ - Repubblica Ceca 9
EC - Ecuador 8
JO - Giordania 7
KR - Corea 7
PH - Filippine 7
PK - Pakistan 7
TH - Thailandia 7
HU - Ungheria 6
LT - Lituania 6
MA - Marocco 6
AZ - Azerbaigian 5
VE - Venezuela 5
AT - Austria 4
BO - Bolivia 4
ES - Italia 4
UZ - Uzbekistan 4
PL - Polonia 3
SA - Arabia Saudita 3
TW - Taiwan 3
CL - Cile 2
CO - Colombia 2
HN - Honduras 2
HR - Croazia 2
IL - Israele 2
KG - Kirghizistan 2
KZ - Kazakistan 2
NP - Nepal 2
PY - Paraguay 2
SN - Senegal 2
TN - Tunisia 2
AE - Emirati Arabi Uniti 1
AM - Armenia 1
CH - Svizzera 1
DK - Danimarca 1
DZ - Algeria 1
ET - Etiopia 1
GT - Guatemala 1
JM - Giamaica 1
LK - Sri Lanka 1
LV - Lettonia 1
NI - Nicaragua 1
PA - Panama 1
PE - Perù 1
PS - Palestinian Territory 1
RO - Romania 1
SI - Slovenia 1
SV - El Salvador 1
TT - Trinidad e Tobago 1
UY - Uruguay 1
VG - Isole Vergini Britanniche 1
ZM - Zambia 1
Totale 4.577
Città #
Singapore 258
Chandler 191
Dublin 188
Ashburn 187
Munich 130
San Jose 120
Ann Arbor 114
Parma 112
Beijing 107
Santa Clara 100
Dallas 93
Ho Chi Minh City 79
Hong Kong 73
Helsinki 58
Hanoi 52
Boardman 51
Dearborn 51
Johannesburg 51
Izmir 47
Shanghai 41
Nanjing 39
Los Angeles 33
New York 33
Jacksonville 30
Princeton 28
Bremen 27
Lauterbourg 24
Wilmington 24
Abidjan 21
São Paulo 19
Columbus 14
Brussels 13
Kunming 13
Shenyang 13
Buffalo 12
Da Nang 12
Rio de Janeiro 12
Hebei 11
Hefei 11
Nanchang 11
Tokyo 11
Düsseldorf 10
San Mateo 10
Turku 10
Guangzhou 9
Haiphong 9
Jakarta 9
Council Bluffs 8
Grafing 8
Hangzhou 8
Jinan 8
Kocaeli 8
Poplar 8
Seattle 8
Toronto 8
Amman 7
Mexico City 7
Montreal 7
Moscow 7
Orem 7
Springfield 7
Stockholm 7
Ankara 6
Chennai 6
Fremont 6
Jiaxing 6
London 6
Modena 6
The Dalles 6
Tianjin 6
Zhengzhou 6
Baku 5
Belo Horizonte 5
Brasília 5
Brooklyn 5
Changsha 5
Denver 5
Frankfurt am Main 5
Fuzhou 5
Manchester 5
Milan 5
Prata Di Pordenone 5
Quito 5
Woodbridge 5
Boston 4
Can Tho 4
Chicago 4
Des Moines 4
Houston 4
Hyderabad 4
Lubbock 4
Manaus 4
Nuremberg 4
Olomouc 4
Palermo 4
Pune 4
San Francisco 4
Sant'ilario D'enza 4
Tashkent 4
Baghdad 3
Totale 2.866
Nome #
Changes in digestive cancer diagnosis during the SARS-CoV-2 pandemic in Italy: A nationwide survey 292
Inhibition of Eph/ephrin interaction with the small molecule UniPR500 improves glucose tolerance in healthy and insulin-resistant mice 239
Optimization of EphA2 antagonists based on a lithocholic acid core led to the identification of UniPR505, a new 3α-carbamoyloxy derivative with antiangiogenetic properties 214
Irreversible Inhibition of Epidermal Growth Factor Receptor Activity by 3-Aminopropanamides. 209
Pharmacological evaluation of new bioavailable small molecules targeting Eph/ephrin interaction 201
Amino acid conjugates of lithocholic acid as antagonists of the EphA2 receptor. 200
UniPR129 is a competitive small molecule Eph-ephrin antagonist blocking in vitro angiogenesis at low micromolar concentrations. 197
Combining ligand- and structure-based approaches for the discovery of new inhibitors of the EPHA2-ephrin-A1 interaction 196
Discovery and development of Eph-ephrin antagonists endowed with antiangiogenic properties 191
Design and structure-activity relationship of amino acid derivatives of lithocholic acid as novel EphA2 antagonists 182
Structure–Activity Relationships and Mechanism of Action of Eph–ephrin Antagonists: Interaction of Cholanic Acid with the EphA2 Receptor 176
270 Discovery, development and optimization of low molecular weight EPH–ephrin protein–protein inhibitors 166
Development of 3-oxo-cholenic derivatives as Eph antagonists able to block in vitro angiogenesis 162
Multiple approaches for the discovery and development of small molecules targeting Eph-ephrin protein-protein interaction 160
Biochemical characterization of EphA2 antagonists with improved physico-chemical properties by cell-based assays and surface plasmon resonance analysis 155
Structure activity relationship of new EphA2 ligands 150
Design and structure-activity relationships of amino acid derivatives of lithocholic acid as novel EphA2 receptor antagonists. 148
Exploiting Free-Energy Minima to Design Novel EphA2 Protein-Protein Antagonists: From Simulation to Experiment and Return 146
Mannich base derivatives as novel EGFR irreversible inhibitors 144
Discovery and development of low molecular weight Eph-ephrin protein-protein inhbi-tors endowed with antiangiogenic activity 144
Combining pharmacology, target hopping and computational medicinal chemistry to discover novel scaffold targeting EPH-ephrin interaction. 142
Metadynamics for perspective drug design: Computationally driven synthesis of new protein-protein interaction inhibitors targeting the EphA2 receptor 138
Target Hopping as a Useful Tool for the Identification of Novel EphA2 Protein–Protein Antagonists 133
Global Prevalence of Protein-Energy Wasting in Kidney Disease: A Meta-analysis of Contemporary Observational Studies From the International Society of Renal Nutrition and Metabolism 123
Target-hopping: a useful approach to identify novel Eph receptor antagonists 122
Synthesis and Structure-Activity Relationships of Amino Acid Conjugates of Cholanic Acid as Antagonists of the EphA2 Receptor. 118
Mechanical vibrations applied to nondestructive evaluation of materials and structures 106
Structure-activity realtionships of new EphaA2 ligands 87
Totale 4.641
Categoria #
all - tutte 13.909
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 13.909


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202160 0 0 0 0 0 0 0 0 0 25 17 18
2021/2022179 9 10 9 38 4 11 14 11 5 12 8 48
2022/2023668 75 84 25 53 70 75 12 36 219 4 13 2
2023/2024219 16 16 5 9 8 35 32 21 10 10 21 36
2024/2025897 27 50 50 53 92 104 108 56 111 56 68 122
2025/20261.621 158 172 155 157 233 115 176 58 278 119 0 0
Totale 4.641